Cardiff, United Kingdom

Daniel Palmer

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Cardiff, GB (2012 - 2021)
  • Oxford, GB (2020 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Palmer

Introduction

Daniel Palmer is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of science and technology, holding a total of 9 patents. His work primarily focuses on advancements in medical applications and nanoparticle production.

Latest Patents

One of Palmer's latest patents is the cyclodextrin-panobinostat adduct. This invention provides a method for producing a cyclodextrin-panobinostat adduct, which includes steps such as preparing an aqueous solution with a buffering agent and mixing it with cyclodextrin. This adduct has potential medical uses, particularly in the treatment of brain tumors. Another significant patent involves the production of nanoparticles. This process entails generating liquid droplets of a metal salt and ligand, which self-assemble into nanoparticles with medical applications.

Career Highlights

Throughout his career, Daniel Palmer has worked with various companies, including Q Chip Limited and Midatech Pharma (Wales) Limited. His innovative work has contributed to advancements in both pharmaceutical and nanotechnology sectors.

Collaborations

Palmer has collaborated with notable individuals in his field, including Owen Lesley Shadick and Robert Huw Davis. These partnerships have further enhanced his research and development efforts.

Conclusion

Daniel Palmer's contributions to innovation and invention are noteworthy, particularly in the realms of medical applications and nanoparticle technology. His patents reflect a commitment to advancing science for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…